FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

67 results

advair
(fluticasone propionate and salmeterol)
GlaxoSmithKline LLC
Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.
albuterol sulfate
(Albuterol Sulfate)
Nephron Pharmaceuticals Corporation
Usage: Albuterol inhalation solution is indicated for relieving bronchospasm in patients aged 2 to 12 with asthma, a condition characterized by reversible obstructive airway disease.
albuterol sulfate inhalation solution
(Albuterol Sulfate)
Ritedose Pharmaceuticals, LLC
Usage: Albuterol Sulfate Inhalation Solution is indicated for relieving bronchospasm in patients aged 2 to 12 years with asthma (reversible obstructive airway disease).
alvesco
(ciclesonide)
Covis Pharma US, Inc
Usage: ALVESCO is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 12 and older. It is not intended for the relief of acute bronchospasm or for children under 12 years of age.
arnuity ellipta
(fluticasone furoate)
GlaxoSmithKline LLC
Usage: ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.
asmanex hfa
(MOMETASONE FUROATE)
Organon LLC
Usage: ASMANEX® HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 5 years and older. It is not intended for relief of acute bronchospasm.
budesonide
(Budesonide)
Cipla USA Inc.
Usage: Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.
budesonide
(Budesonide)
Sandoz Inc
Usage: Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.
budesonide
(Budesonide)
Sun Pharmaceutical Industries, Inc.
Usage: Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.
budesonide
(Budesonide)
Teva Pharmaceuticals USA, Inc.
Usage: Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.

Medications for Asthma

advair

albuterol sulfate

albuterol sulfate inhalation solution

alvesco

arnuity ellipta

asmanex hfa

budesonide

budesonide

budesonide

budesonide